Healthcare
Three AI-Designed Drug Candidates Enter Phase 1 Clinical Trials
Isomorphic Labs, Recursion Pharmaceuticals, and Insilico Medicine each advance AI-designed drug candidates into Phase 1 clinical trials, marking a significant milestone for AI-driven drug discovery.
2025年6月7日来源：Isomorphic Labs
drug-discoveryAI-healthcareclinical-trialsAlphaFoldbiotech